Literature DB >> 24457476

T cells: Spotting the troublemakers.

Yvonne Bordon.   

Abstract

Mesh：

Substances：

Year:  2014        PMID： 24457476     DOI： 10.1038/nri3610

Source DB:  PubMed          Journal:  Nat Rev Immunol        ISSN： 1474-1733            Impact factor:   53.106


× No keyword cloud information.
  1 in total

1.  Pro-inflammatory human Th17 cells selectively express P-glycoprotein and are refractory to glucocorticoids.

Authors:  Radha Ramesh; Lina Kozhaya; Kelly McKevitt; Ivana M Djuretic; Thaddeus J Carlson; Maria A Quintero; Jacob L McCauley; Maria T Abreu; Derya Unutmaz; Mark S Sundrud
Journal:  J Exp Med       Date:  2014-01-06       Impact factor: 14.307
  1 in total
  4 in total

Review 1.  Th17.1 lymphocytes: emerging players in the orchestra of immune-mediated inflammatory diseases.

Authors:  Durga Prasanna Misra; Vikas Agarwal
Journal:  Clin Rheumatol       Date:  2022-05-11       Impact factor: 3.650

2.  Tacrolimus induces remission in refractory and relapsing lupus nephritis by decreasing P-glycoprotein expression and function on peripheral blood lymphocytes.

Authors:  Sukesh Edavalath; Mohit Kumar Rai; Vikas Gupta; Ravi Mishra; Durga Prasanna Misra; Latika Gupta; Vikas Agarwal
Journal:  Rheumatol Int       Date:  2022-01-07       Impact factor: 3.580

3.  Vitamin D Counteracts an IL-23-Dependent IL-17A+IFN-γ+ Response Driven by Urban Particulate Matter.

Authors:  Elizabeth H Mann; Tzer-Ren Ho; Paul E Pfeffer; Nick C Matthews; Elfy Chevretton; Ian Mudway; Frank J Kelly; Catherine M Hawrylowicz
Journal:  Am J Respir Cell Mol Biol       Date:  2017-09       Impact factor: 6.914

4.  Novel Th17 Lymphocyte Populations, Th17.1 and PD1+Th17, are Increased in Takayasu Arteritis, and Both Th17 and Th17.1 Sub-Populations Associate with Active Disease.

Authors:  Kritika Singh; Upendra Rathore; Mohit Kumar Rai; Manas R Behera; Neeraj Jain; Manish Ora; Dharmendra Bhadauria; Supriya Sharma; Gaurav Pande; Sanjay Gambhir; Alok Nath; Sudeep Kumar; Aman Sharma; Vikas Agarwal; Durga Prasanna Misra
Journal:  J Inflamm Res       Date:  2022-03-01
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.